Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram

Salvatore Maria Corsello, Agnese Barnabei, Lidia Strigari, Paolo Marchetti, Valentina Sini, Liana De Vecchis, Francesco Torino

Risultato della ricerca: Contributo in rivistaArticolo in rivista

10 Citazioni (Scopus)

Abstract

The assessment of ovarian reserve in premenopausal women requiring anticancer gonadotoxic therapy can help clinicians address some challenging issues, including the probability of future pregnancies after the end of treatment. Anti-Müllerian hormone (AMH) and age can reliably estimate ovarian reserve. A limited number of studies have evaluated AMH and age as predictors of residual ovarian reserve following cytotoxic chemotherapy in breast cancer patients.
Lingua originaleEnglish
pagine (da-a)1111-1118
Numero di pagine8
RivistaTHE ONCOLOGIST
Volume20
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Anti-Müllerian hormone
  • Breast cancer
  • Ovarian reserve
  • Ovarian toxicity
  • Predictive factors

Fingerprint Entra nei temi di ricerca di 'Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based Nomogram'. Insieme formano una fingerprint unica.

Cita questo